Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02267603 · MORE INFO

Limitations, agreements, and source contact

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer · Source last updated 2023-07-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
citn.core.reg@hvtn.org
organization
Cancer Immunotherapy Trials Network
phone
206-667-6609
title
Administrative Director
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
citn.core.reg@hvtn.org
organization
Cancer Immunotherapy Trials Network
phone
206-667-6609
title
Administrative Director

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice